losartan has been researched along with eicosapentaenoic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Appel, G; Bay, RC; Carter, B; Cattran, D; Cerda, J; Fervenza, FC; Fischer, D; Gipson, D; Hernandez, G; Hogg, RJ; Hurley, RM; Jennette, JC; Jung, B; Kumar, S; Sibley, R; Wyatt, RJ | 1 |
| Ambrosius, WT; Anton, SD; Beavers, DP; Cauley, JA; Espeland, MA; Fielding, RA; Kritchevsky, SB; Leeuwenburgh, C; Lewis, KH; Liu, C; Lu, J; Manini, TM; McDermott, MM; Miller, ME; Newman, AB; Pahor, M; Radziszewska, B; Stowe, C; Tracy, RP; Walston, JD; Wu, S | 1 |
| Altamimy, R; Amoura, L; Auger, C; El Habhab, A; El Itawi, H; Farooq, MA; Hasan, H; Kassem, M; Qureshi, AW; Schini-Kerth, V; Toti, F; Zobairi, F | 1 |
2 trial(s) available for losartan and eicosapentaenoic acid
| Article | Year |
|---|---|
Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Child; Creatinine; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Lisinopril; Losartan; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Remission Induction; Treatment Outcome; Young Adult | 2015 |
ENabling Reduction of Low-grade Inflammation in SEniors Pilot Study: Concept, Rationale, and Design.
Topics: Aged; Antihypertensive Agents; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; Inflammation; Interleukin-6; Losartan; Male; Mobility Limitation; Pilot Projects | 2017 |
2 other study(ies) available for losartan and eicosapentaenoic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Ageing enhances the shedding of splenocyte microvesicles with endothelial pro-senescent effect that is prevented by a short-term intake of omega-3 PUFA EPA:DHA 6:1.
Topics: Aging; Animals; Antihypertensive Agents; Biomarkers; Cell-Derived Microparticles; Cells, Cultured; Cellular Senescence; Coronary Vessels; Docosahexaenoic Acids; Eicosapentaenoic Acid; Endothelial Cells; Endothelium, Vascular; Fatty Acids, Omega-3; Losartan; Male; Rats, Wistar; Reactive Oxygen Species; Spleen; Swine | 2020 |